Early perfusion changes in patients with recurrent high-grade brain tumor treated with Bevacizumab: preliminary results by a quantitative evaluation

BACKGROUND: To determine whether early monitoring of the effects of bevacizumab in patients with recurrent high-grade gliomas, by a Perfusion Computed Tomography (PCT), may be a predictor of the response to treatment assessed through conventional MRI follow-up. METHODS: Sixteen patients were enrolle...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Vidiri, Antonello, Pace, Andrea, Fabi, Alessandra, Maschio, Marta, Latagliata, Gaetano Marco, Anelli, Vincenzo, Piludu, Francesca, Carapella, Carmine Maria, Giovinazzo, Giuseppe, Marzi, Simona
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2012
Gaiak:
Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3583244/
https://ncbi.nlm.nih.gov/pubmed/22494770
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-9966-31-33
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak